🔎 Trials Near Me

Home › Acute Myeloid Leukemia › California › Mountain View

Acute Myeloid Leukemia clinical trials in Mountain View, CA

19 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RecruitingPhase 1
  • Stanford Health Care, Stanford · 5 mi away
Ages 12 to 78 · All sexes · Updated Sep 29, 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi away
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecruitingPhase 2
  • Stanford Cancer Institute, Stanford · 5 mi away
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

RecruitingPhase 1
  • Lucile Packard Children's Hospital /ID# 276015, Palo Alto · 5 mi away
6 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07306832

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

RecruitingPhase 1
  • Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi away
18 Months – 39 Years · All sexes · Updated Aug 21, 2026 · NCT07573111

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07302776

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 2 to 25 · All sexes · Updated Aug 12, 2026 · NCT05188170

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Stanford University Medical Center, Stanford · 5 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 18 to 70 · All sexes · Updated Jun 23, 2026 · NCT06551584

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RecruitingPhase 1
  • Stanford University, Stanford · 5 mi away
Up to age 21 · All sexes · Updated Apr 22, 2026 · NCT05101551

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

RecruitingPhase 1/2
  • Stanford University, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06561152

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecruitingPhase 1/2
  • Stanford University, Palo Alto · 5 mi away
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

RecruitingPhase 1
  • Stanford Medical Center, Palo Alto · 5 mi away
Ages 12 and older · All sexes · Updated Mar 16, 2026 · NCT06994676

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

RecruitingPhase 1
  • Stanford University, Stanford · 5 mi away
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT06950034

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RecruitingPhase 1
  • Stanford Cancer Center, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

RecruitingPhase 1/2
  • Stanford Cancer Center, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Aug 26, 2025 · NCT03850574

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RecruitingHealthy volunteers welcome
  • Stanford University, Stanford · 5 mi away
Ages 18 to 120 · All sexes · Updated Jul 25, 2025 · NCT05237258

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Mountain View

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.